Tennessee Alzheimer's Project
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · May 11, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Tennessee Alzheimer's Project is a clinical trial aimed at understanding Alzheimer's disease and related conditions. Researchers at the Vanderbilt Alzheimer's Disease Research Center (VADRC) want to gather information from a diverse group of participants to help improve early detection, prevention, and treatment of Alzheimer's. They plan to enroll up to 1,000 individuals aged 60 and older who may be cognitively healthy, have mild cognitive impairment, or have been diagnosed with Alzheimer's disease. The goal is to create a strong foundation for future research by collecting clinical data, brain scans, and biological samples.
If you or a loved one are interested in participating, you'll need to be at least 60 years old, speak English, and fit into one of the cognitive categories mentioned earlier. Unfortunately, individuals with certain serious mental health issues or neurological conditions, as well as those who can't undergo an MRI scan, won't be able to join. Participants will visit the center once a year for thorough evaluations and may also be referred to other studies that could enhance Alzheimer's research. Your involvement could help pave the way for better understanding and treatment of this challenging disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 60 or older
- • Meet standard criteria for (a) cognitively unimpaired, (b) mild cognitive impairment, or (c) Alzheimer's disease
- • English speaking
- • Individuals who lack decisional capacity to provide informed consent at baseline will not be enrolled in the study
- Exclusion Criteria:
- • No available reliable study partner (reliable is defined as someone who interacts significantly with the participant and is available to participate in study visits in person or by phone)
- • History of major psychiatric illness (e.g., schizophrenia, bipolar), neurological illness (e.g., epilepsy, multiple sclerosis, Parkinson's disease), or head injury with significant loss of consciousness.
- • Unable to undergo MRI (e.g., claustrophobia, ferrous metal in body)
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Trial Officials
Angela Jefferson, PhD
Principal Investigator
Professor of Neurology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials